Navigation Links
PROLOR Biotech Announces Initiation of Phase I Clinical Trial for its Long-Acting Growth Hormone
Date:9/21/2009

pment of hGH-CTP."

ABOUT hGH-CTP

hGH-CTP is PROLOR's proprietary long-acting version of human growth hormone. hGH is used for the long-term treatment of children and adults with growth failure due to inadequate secretion of endogenous growth hormone. It is also sometimes used to counter involuntary weight loss and certain physical manifestations of aging. Patients currently using hGH must inject the drug between two and seven times each week. In contrast, hGH-CTP is expected to require only weekly or bi-monthly injections. In 2007 the annual market for hGH was estimated at $2.5 billion.

ABOUT CTP

PROLOR's CTP technology is based on an amino acid sequence that occurs naturally in humans, the carboxyl terminal peptide. When attached to a therapeutic protein, CTP extends the time that the protein is active in the body. The potential utility of the technology has been demonstrated by Schering-Plough, which in 2009 announced successful data from its Phase III ENGAGE trial demonstrating that women receiving a single injection of the fertility drug FSH-CTP achieved the same pregnancy rates as women receiving seven consecutive daily injections of commercial FSH. This 1,509 patient trial formed the basis for a Marketing Authorization Application by Schering-Plough that is currently under review by the European Medicines Agency. PROLOR is using the same CTP technology to extend the duration of action of human growth hormone and other therapeutic proteins. It has an exclusive license from Washington University in St. Louis to the CTP technology for use with all therapeutic proteins except for the four fertility hormones licensed to Schering-Plough.

ABOUT PROLOR BIOTECH

PROLOR Biotech, Inc. is a biopharmaceutical company applying unique technologies, including its patented CTP technology, primarily to develop longer-acting, proprietary versions of already approved thera
'/>"/>

SOURCE PROLOR Biotech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. PROLOR Biotech Awarded Two U.S. Patents for Its Longer-Acting Human Growth Hormone and Longer-Acting Erythropoietin
2. PROLOR Biotech Announces $10 Million Preferred Stock Line From Members of The Frost Group
3. PROLOR Biotech Acquires License Option from Yeda for Development of Long-Acting Anti-Obesity Drug
4. PROLOR Biotech to Present at the UBS 2009 Global Life Sciences Conference
5. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego
8. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
9. Finkelstein Thompson LLP Announces GPC Biotech AG Investigation
10. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
11. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)..., British Columbia, Dec. 1 /PRNewswire-FirstCall/ ... of The Dow Chemical Company (NYSE: DOW ), and A...ing of a research and commercial license option ag...ith access to Agrisoma,s proprietary Engineered Tr... major food crops, and on a non-exclusive basis, i...
(Date:12/1/2009)...ing provider of products for biological sample col...l Services will offer Oragene•DNA sample coll... and genotyping service. , ...tek , a leading provider of products for biologica...Pharmaceutical Services will offer Oragene•...
(Date:12/1/2009)... 34-year veteran of the high-technology industry, ...s development and intellectual property management...ace. The company also plans to invest in promisin...or. , Monterey, CA (PRWEB...r veteran of the high-technology industry, has for...
(Date:11/30/2009)...Newswire/ -- The Michael J. Fox Foundation for Par...ion in total awards to six research teams working ... for Parkinson,s disease. The funding was awarded ...Parkinson,s Disease program, made possible by fun...neuroscience-based biotechnology company. ,, T...
Breaking Biology Technology:Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 2Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 3Tepnel Pharmaceutical Services to Offer DNA Genotek's Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 2Tepnel Pharmaceutical Services to Offer DNA Genotek's Sample Collection Kit in its Nucleic Acid Extraction and Genotyping Service 3Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 2Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 3Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 4The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 3
...DW Corp. , the Illinois-based technology provider ...s , is elevating a top salesman to handle Berbee,s...put vice president of sales Steven Schuldt in char...olutions provider, into CDW. , ,CDW, headquartered...d Berbee on Oct. 11 for approximately $184 million...
... is the second in a series of articles on developi...nology realm. The first edition of Early Stage f..., , Madison, Wis. - So now that you know you ha...nology, either one of which could be branded, what... will discuss how you pick your business name. In ...
... There are signs the United States economy is cool...ting in the third quarter is not one of them, acco...capitalists invested $6.2 billion in 797 deals dur...decline in both categories, according to a MoneyT...ational Venture Capital Association based on data...
Other Biology Technology:Early Stage Step 2: Choosing a domain name 2Early Stage Step 2: Choosing a domain name 3Early Stage Step 2: Choosing a domain name 4Venture capital above $6B for third straight quarter 2Venture capital above $6B for third straight quarter 3
(Date:12/1/2009)...Particularly in Alzheimer,s disease, nerve cell de...w therapeutic options may possibly be derived from...m. These findings have been published in the curre...nce . Until only a few years ago, neurogenesis th...d to be impossible in the adult brain. The textboo...
(Date:12/1/2009)...Yehezkel Ben-Ari, winner of the 2009 Inserm Grand ...d its commitment to paying tribute to outstanding,...s. By honouring talents, Inserm intends to,demons...ved in today,s biological, medical and,health res...nd women who carry out and,drive this research ea...
(Date:12/1/2009)...In a world first, a Monash University-led internat...y to boost the output of the next generation of so... collaboration with colleagues from the universiti... tandem dye-sensitised solar cells with a three-fo...ed with previously reported tandem dye-sensitised ...
Breaking Biology News(10 mins):New source discovered for the generation of nerve cells in the brain 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 3Innovation puts next-generation solar cells on the horizon 2Cardium Announces Plans to File FDA 510 28k 29 Application for U S Marketing Clearance of ExcellagenXL 28TM 29 Gel for Diabetic Pressure and Venous 14682 1Cardium Announces Plans to File FDA 510 28k 29 Application for U S Marketing Clearance of ExcellagenXL 28TM 29 Gel for Diabetic Pressure and Venous 14682 2Cardium Announces Plans to File FDA 510 28k 29 Application for U S Marketing Clearance of ExcellagenXL 28TM 29 Gel for Diabetic Pressure and Venous 14682 3Cardium Announces Plans to File FDA 510 28k 29 Application for U S Marketing Clearance of ExcellagenXL 28TM 29 Gel for Diabetic Pressure and Venous 14682 4China National Medicines Corporation Issues Milestone Purchase Order for 12 000 STA Systems 5913 1China National Medicines Corporation Issues Milestone Purchase Order for 12 000 STA Systems 5913 2China National Medicines Corporation Issues Milestone Purchase Order for 12 000 STA Systems 5913 3China National Medicines Corporation Issues Milestone Purchase Order for 12 000 STA Systems 5913 4Global Atrial Fibrillation Device Market to Grow by Almost 10 25 Through 2013 5910 1Global Atrial Fibrillation Device Market to Grow by Almost 10 25 Through 2013 5910 2Global Atrial Fibrillation Device Market to Grow by Almost 10 25 Through 2013 5910 3
...at help shape our understanding of how tool use ha...red evidence that chimpanzees, at least under some...and using tools to hunt mammalian prey. The work, ...nd Paco Bertolani of the University of Cambridge, ...on February 22nd. , Chimpanzees are well known for...
...ersion of a computer chip, a team led by Johns Hop...y related to the mating habits of yeast cells. ,...line Publication of the journal Nature, shed new l...m one another and from the environment through a p...hen impaired, can lead to cancer or other illnesse...
...tion and large scale culture of stem cells for pot...n cell biology. In an upcoming PLoS ONE paper, res...y, France) report, on the basis of experimental ob... cell identity in culture may strongly depend on t...s are in line with the currently emerging view tha...
Other Biology News:Chimpanzees found to use tools to hunt mammalian prey 2Microfluidic chip helps solve cellular mating puzzle 2Microfluidic chip helps solve cellular mating puzzle 3
Wheat Germ Agglutinin (WGA) PS SPA Imaging Bead from GE Healthcare, formerly Amersham Biosciences
...s to 1 outflow Single-cell and patch delivery Re...illisecond) solution change Very small dead volum...Solid construction 360, 250 and 100 micron delive...manipulator Available in 4, 8, and 16 channels. S...
Sf21 Frozen Cells (Grace's Media) from Invitrogen
... most comprehensive, cost-effective solution to yo...orated unprecedented quality into both our product...etection chemistries and antibodies that have been...des our competitively priced accessories that can ...
Biology Products: